Taiwo Oladapo

Array ( [id] => 5699586 [patent_doc_number] => 20060216270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'DNA 19355 polypeptide, a tumor necrosis factor homolog' [patent_app_type] => utility [patent_app_number] => 11/353441 [patent_app_country] => US [patent_app_date] => 2006-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19866 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216270.pdf [firstpage_image] =>[orig_patent_app_number] => 11353441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5677395 [patent_doc_number] => 20060182750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Process for preparing stable drug conjugates' [patent_app_type] => utility [patent_app_number] => 11/352121 [patent_app_country] => US [patent_app_date] => 2006-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15961 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20060182750.pdf [firstpage_image] =>[orig_patent_app_number] => 11352121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5209951 [patent_doc_number] => 20070248535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Methods to treat or prevent hormone-resistant prostate cancer using siRNA specific for protocadherin-PC, or other inhibitors of protocadherin-PC expression or activity' [patent_app_type] => utility [patent_app_number] => 11/349473 [patent_app_country] => US [patent_app_date] => 2006-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 65029 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20070248535.pdf [firstpage_image] =>[orig_patent_app_number] => 11349473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5178045 [patent_doc_number] => 20070179105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'Method and means for treating solid tumors' [patent_app_type] => utility [patent_app_number] => 11/343694 [patent_app_country] => US [patent_app_date] => 2006-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8547 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20070179105.pdf [firstpage_image] =>[orig_patent_app_number] => 11343694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5613543 [patent_doc_number] => 20060115471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Treatment of disease with antibodies against high molecular weight kininogen domain 5' [patent_app_type] => utility [patent_app_number] => 11/343003 [patent_app_country] => US [patent_app_date] => 2006-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6685 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20060115471.pdf [firstpage_image] =>[orig_patent_app_number] => 11343003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5242842 [patent_doc_number] => 20070021337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Novel agent for inducing apoptosis comprising Msx1 or a gene encoding the same as an active ingredient' [patent_app_type] => utility [patent_app_number] => 11/344633 [patent_app_country] => US [patent_app_date] => 2006-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8630 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021337.pdf [firstpage_image] =>[orig_patent_app_number] => 11344633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596240 [patent_doc_number] => 20060160157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Method, compositions and classification for tumor diagnostics and treatment' [patent_app_type] => utility [patent_app_number] => 11/334845 [patent_app_country] => US [patent_app_date] => 2006-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13794 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160157.pdf [firstpage_image] =>[orig_patent_app_number] => 11334845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5595773 [patent_doc_number] => 20060159689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Combinations of tumor-associated antigens in diagnostics for various types of cancers' [patent_app_type] => utility [patent_app_number] => 11/323964 [patent_app_country] => US [patent_app_date] => 2005-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23916 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20060159689.pdf [firstpage_image] =>[orig_patent_app_number] => 11323964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6473253 [patent_doc_number] => 20100041167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'DRUG FOR DIAGNOSING LARGE INTESTINAL CANCER AND/OR POLYP, OBSERVING POSTOPERATIVE COURSE AND MONITORING RECURRENCE' [patent_app_type] => utility [patent_app_number] => 11/721882 [patent_app_country] => US [patent_app_date] => 2005-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9755 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041167.pdf [firstpage_image] =>[orig_patent_app_number] => 11721882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4521043 [patent_doc_number] => 07951374 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Methods for inhibiting STAT3 signaling in immune cells' [patent_app_type] => utility [patent_app_number] => 11/300619 [patent_app_country] => US [patent_app_date] => 2005-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 40 [patent_no_of_words] => 9365 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951374.pdf [firstpage_image] =>[orig_patent_app_number] => 11300619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5842246 [patent_doc_number] => 20060121040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Compositions and methods for treating neuroendocrine tumors' [patent_app_type] => utility [patent_app_number] => 11/296404 [patent_app_country] => US [patent_app_date] => 2005-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15640 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121040.pdf [firstpage_image] =>[orig_patent_app_number] => 11296404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479827 [patent_doc_number] => 20100092499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Alpha Thymosin Peptides as Cancer Vaccine Adjuvants' [patent_app_type] => utility [patent_app_number] => 11/720909 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10244 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092499.pdf [firstpage_image] =>[orig_patent_app_number] => 11720909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4954489 [patent_doc_number] => 20080187513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Treatment of Solid Cancers' [patent_app_type] => utility [patent_app_number] => 11/792264 [patent_app_country] => US [patent_app_date] => 2005-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15820 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20080187513.pdf [firstpage_image] =>[orig_patent_app_number] => 11792264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5843335 [patent_doc_number] => 20060121541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Use of endosialin binding proteins to isolate endosialin positive cells' [patent_app_type] => utility [patent_app_number] => 11/292634 [patent_app_country] => US [patent_app_date] => 2005-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8669 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121541.pdf [firstpage_image] =>[orig_patent_app_number] => 11292634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859125 [patent_doc_number] => 20080267975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Mer Diagnostic and Therapeutic Agents' [patent_app_type] => utility [patent_app_number] => 11/720185 [patent_app_country] => US [patent_app_date] => 2005-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 30089 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267975.pdf [firstpage_image] =>[orig_patent_app_number] => 11720185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 232618 [patent_doc_number] => 07598043 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-06 [patent_title] => 'Use of vascular endothelial growth factor receptor 1+ cells in treating and monitoring cancer and in screening for chemotherapeutics' [patent_app_type] => utility [patent_app_number] => 11/284265 [patent_app_country] => US [patent_app_date] => 2005-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 46 [patent_no_of_words] => 15176 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/598/07598043.pdf [firstpage_image] =>[orig_patent_app_number] => 11284265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5913568 [patent_doc_number] => 20060128630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents' [patent_app_type] => utility [patent_app_number] => 11/280954 [patent_app_country] => US [patent_app_date] => 2005-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 3818 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128630.pdf [firstpage_image] =>[orig_patent_app_number] => 11280954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4525247 [patent_doc_number] => 07951924 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'RhoB variants and methods of use' [patent_app_type] => utility [patent_app_number] => 11/274368 [patent_app_country] => US [patent_app_date] => 2005-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 16994 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951924.pdf [firstpage_image] =>[orig_patent_app_number] => 11274368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 820689 [patent_doc_number] => 07408022 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'Composition and method for increasing apoptosis in cancer cells' [patent_app_type] => utility [patent_app_number] => 11/270295 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 20 [patent_no_of_words] => 9113 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/408/07408022.pdf [firstpage_image] =>[orig_patent_app_number] => 11270295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 575788 [patent_doc_number] => 07459529 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-02 [patent_title] => 'AIMP2-DX2 and its uses' [patent_app_type] => utility [patent_app_number] => 11/264725 [patent_app_country] => US [patent_app_date] => 2005-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 43 [patent_no_of_words] => 13517 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/459/07459529.pdf [firstpage_image] =>[orig_patent_app_number] => 11264725 [rel_patent_id] =>[rel_patent_doc_number] =>)